摘要
目的:探讨恶性淋巴瘤与乙型肝炎病毒感染间的关系。方法:收集云南某医院住院治疗的淋巴瘤患者相关实验室检查指标等,并进行分析。结果:某医院就诊的淋巴瘤患者年龄多在40~59岁,霍奇金淋巴瘤与非霍奇金淋巴瘤患者淋巴细胞绝对值及百分比、LDH、ESR等结果差异无统计学意义。霍奇金淋巴瘤患者中行HBsAg检测的阳性率11.11%,非霍奇金淋巴瘤患者HbsAg阳性率44.44%。结论:在淋巴瘤患者化疗前需行乙肝两对半检测,如为HBV感染者需预防性使用拉米夫定等抑制乙肝病毒复制药物,直至化疗结束后6个月,且满足疗程至少1年。
Objective:To discuss the relationship between malignant lymphoma and hepatitis B infection.Methods:To collect relevant laboratory examination indexes of lymphoma patients with hospitalization in a hospital in YunNan.Results:The age of lymphoma patients in a hospital were 40~59 years old.Lymphocyte absolute value,percentage,LDH,ESR ect of patients with hodgkin lymphoma and non-hodgkin lymphoma,have no statistical difference.The positive rate of HBsAg testing in patients with hodgkin lymphoma was 11.11%,while the positive rate of HBsAg testing in patients with non-hodgkin lymphoma was 44.44%. Conclusion:Patients with lymphoma need to do second liver two half-and-half detect before chemotherapy,if the patient was HBsAg-positive that need to preventive using lamivudine ect suppress HBV replication medicine,and until the end of chemotherapy after 6 months,and meet the course at least 1 year.
